Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K4MU
|
||||
Former ID |
DIB006039
|
||||
Drug Name |
CROBENETINE HYDROCHLORIDE
|
||||
Synonyms |
CROBENETINE; CROBENETINE); BIII-890-CL; Crobenetine < Prop INN >; Crobenetine hydrochloride < Prop INNM >; (2R,6S)-3-[2(S)-Benzyloxypropyl]-6,11,11-trimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ol; (2R,6S)-3-[2(S)-Benzyloxypropyl]-6,11,11-trimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ol hydrochloride
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Phase 2 | [524933] | ||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C[C@@H](CN1CC[C@H]2c3ccccc3C[C@@H]1C2(C)C)OCc4ccccc4
|
||||
InChI |
1S/C24H31NO/c1-18(26-17-19-9-5-4-6-10-19)16-25-14-13-22-21-12-8-7-11-20(21)15-23(25)24(22,2)3/h4-12,18,22-23H,13-17H2,1-3H3/t18-,22-,23+/m0/s1
|
||||
InChIKey |
ILVITZMPXQQPBD-OFAXGOBFSA-N
|
||||
CAS Number |
CAS 221019-25-6
|
||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Antagonist | [526220], [551871] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.